(Q34192772)

31 July 2017

Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings (English)

1 reference

31 July 2017

0 references

Patrick Santens

6

0 references

author name string

J Versijpt

1

1 reference

31 July 2017

K J Van Laere

2

1 reference

31 July 2017

F Dumont

3

1 reference

31 July 2017

Danny Decoo

4

1 reference

31 July 2017

Marleen Vandecapelle

5

1 reference

31 July 2017

Ingeborg Goethals

7

1 reference

31 July 2017

K Audenaert

8

1 reference

31 July 2017

G Slegers

9

1 reference

31 July 2017

Rudi A Dierckx

10

1 reference

31 July 2017

Jakob Korf

11

1 reference

31 July 2017

1 July 2003

1 reference

31 July 2017

Neurobiology of Aging

1 reference

31 July 2017

24

1 reference

31 July 2017

4

1 reference

31 July 2017

553-561

1 reference

Inflammation and Alzheimer's disease

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Variability in the 5-HT(2A) receptor gene is associated with seasonal pattern in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

A review of central 5-HT receptors and their function

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Sex difference in 5HT2 receptor in the living human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Serotonin receptors in cognitive behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Role of serotonin in memory impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Serotonin receptor changes in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

The influence of prolactin response to d-fenfluramine on executive functioning in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Modulation of central cholinergic activity by GABA and serotonin: PET studies with 11C-benztropine in primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

1 reference

7 January 2021

Evaluation of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

5-HT system and cognition

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Role of serotonin in the immune system and in neuroimmune interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Regulation of APP processing. Potential for the therapeutical reduction of brain amyloid burden

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Greater loss of 5-HT(2A) receptors in midlife than in late life

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Aging and Alzheimer's disease. Altered cortical serotonergic binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

Development and validation of a geriatric depression screening scale: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900137-9

7 January 2021

10.1016/S0197-4580(02)00137-9

Identifiers

DOI

1 reference

31 July 2017

1 reference